Similar to what has been previously reported, the patients with CAD showed a longer duration of T2DM, a higher incidence of hypertension, and increases in insulin usage and the frequency of statin treatment in addition to elevated levels of traditional CAD risk factors, such as dyslipidemia, Cys-C and a declined level of eGFR. The gene discussed is INS; the disease is Hypertension.